Journal ArticleJ Pain · December 2024
We aimed to determine the minimal clinically important difference (MCID) in pain severity and agreement between the visual analog scale (VAS) and the verbal numeric rating scale (NRS) in people with sickle cell disease (SCD) experiencing an acute vaso-occl ...
Full textLink to itemCite
Journal ArticleJ Gerontol A Biol Sci Med Sci · November 1, 2024
BACKGROUND: Sickle cell disease (SCD) is a chronic medical condition characterized by red blood cell sickling, vaso-occlusion, hemolytic anemia, and subsequently, end-organ damage and reduced survival. Because of this significant pathophysiology and early ...
Full textLink to itemCite
Journal ArticleBlood Adv · October 29, 2024
Disease-modifying therapies are standard of care (SOC) for sickle cell disease (SCD), but hematopoietic cell transplantation (HCT) has curative potential. We compared outcomes prospectively through 2-years after biologic assignment to a Donor or No Donor ( ...
Full textLink to itemCite
Journal ArticleAm J Hematol · October 2024
Central nervous system (CNS) injury is common in sickle cell disease (SCD) and occurs early in life. Hydroxyurea is safe and efficacious for treatment of SCD, but high-quality evidence from randomized trials to estimate its neuroprotective effect is scant. ...
Full textLink to itemCite
Journal ArticleBlood Adv · September 10, 2024
Children and adults with sickle cell disease (SCD) have increases in morbidity and mortality with COVID-19 infections. The American Society of Hematology Research Collaborative Sickle Cell Disease Research Network performed a prospective COVID-19 vaccine s ...
Full textLink to itemCite
Journal ArticleMMWR Morb Mortal Wkly Rep · March 28, 2024
Sickle cell disease (SCD) remains a public health priority in the United States because of its association with complex health needs, reduced life expectancy, lifelong disabilities, and high cost of care. A cross-sectional analysis was conducted to calcula ...
Full textOpen AccessLink to itemCite
Journal ArticleBlood · February 29, 2024
Fifty years ago, people with sickle cell disease (SCD) were discouraged from becoming pregnant, but now, most should be supported if they choose to pursue a pregnancy. They and their providers, however, should be aware of the physiological changes of pregn ...
Full textLink to itemCite
Journal ArticleBlood · January 25, 2024
Cell-surface exposure of phosphatidylserine (PS) is essential for phagocytic clearance and blood clotting. Although a calcium-activated phospholipid scramblase (CaPLSase) has long been proposed to mediate PS exposure in red blood cells (RBCs), its identity ...
Full textLink to itemCite
Journal ArticleJoint Commission Journal on Quality and Patient Safety · January 1, 2024
Sickle cell disease (SCD) is a life-limiting multisystem disease primarily affecting individuals of African and Latinx descent. Its most common complication is painful vaso-occlusive episodes (VOEs), which is also the most common reason individuals with SC ...
Full textCite
Journal ArticleAcad Emerg Med · December 2023
BACKGROUND: Vaso-occlusive crises (VOCs) cause debilitating pain and are a common cause of emergency department (ED) visits, for people with sickle cell disease (SCD). Strategies for achieving optimal pain control vary widely despite evidence-based guideli ...
Full textOpen AccessLink to itemCite
ConferenceBlood · November 2, 2023
The ability to characterize the modern person living with SCD in the US has been limited by the lack of a well-curated longitudinal registry. The Globin Research Network for Data and Discovery ( GRNDaD) registry aims to ...
Full textCite
ConferenceBlood · November 2, 2023
BackgroundImprovements in care over the last 50 years have extended the median lifespan of people living with sickle cell disease (SCD) from 14 years to as long as 61 years in cohorts fr ...
Full textCite
ConferenceBlood · November 2, 2023
BackgroundOlder adults with sickle cell disease (SCD) (defined as age ≥ 40 years) experience both SCD and age-related conditions such as recurrent pain episodes, avascular necrosis of th ...
Full textCite
ConferenceBlood · November 2, 2023
IntroductionSickle Cell Disease (SCD) is a genetic disorder that causes recurrent vaso-occlusive pain events, functional impairment, and nutritional deficiencies due to increased metabol ...
Full textCite
ConferenceBlood · November 2, 2023
IntroductionWith medical advancements over the past decades, the life expectancy for people with sickle cell disease (SCD) is longer than ever before. As they age, people with SCD acquir ...
Full textCite
ConferenceBlood · November 2, 2023
A multi-state, long term follow-up study of individuals with sickle cell disease (SCD) demonstrated an increase in mortality and morbidity in children and adults with COVID. mRNA vaccines are recommended for all SCD pat ...
Full textCite
ConferenceBlood · November 2, 2023
IntroductionAs people with sickle cell disease (SCD) age, they experience accelerated functional decline. Since historically survival for SCD has been limited to middle age, geriatric sy ...
Full textCite
Journal ArticleBMJ Qual Saf · October 2023
Hydroxyurea (HU) is an effective but underused disease-modifying therapy for patients with sickle cell anaemia (SCA). EMBRACE SCD, a sickle cell disease treatment demonstration project, aimed to improve access to HU by increasing prescription (Rx) rates by ...
Full textLink to itemCite
Journal ArticleJAMIA Open · July 2023
OBJECTIVE: Population-level data on sickle cell disease (SCD) are sparse in the United States. The Centers for Disease Control and Prevention (CDC) is addressing the need for SCD surveillance through state-level Sickle Cell Data Collection Programs (SCDC). ...
Full textOpen AccessLink to itemCite
Journal ArticleGait Posture · May 2023
BACKGROUND: Sickle cell disease (SCD) is a genetic disorder that causes physical and cognitive impairment due to hemolysis, painful vaso-occlusion episodes, joint avascular necrosis, and strokes. As individuals with SCD age and develop conditions impacting ...
Full textLink to itemCite
Journal ArticleDrugs Aging · April 2023
People with sickle cell disease (SCD) are living longer than ever before, with the median survival increasing from age 14 years in 1973, beyond age 40 years in the 1990s, and as high as 61 years in recent cohorts from academic centers. Improvements in surv ...
Full textLink to itemCite
Journal ArticleDrug Saf · March 2023
INTRODUCTION: Detection of adverse reactions to drugs and biologic agents is an important component of regulatory approval and post-market safety evaluation. Real-world data, including insurance claims and electronic health records data, are increasingly u ...
Full textLink to itemCite
Journal ArticleStroke · November 2022
BACKGROUND: Hemorrhagic stroke in young patients with sickle cell anemia remains poorly characterized. METHODS: The Post-STOP (Stroke Prevention Trial in Sickle Cell Anemia) retrospective study collected follow-up data on STOP and STOP II clinical trial co ...
Full textLink to itemCite
Journal ArticlePediatr Blood Cancer · October 2022
BACKGROUND: Adolescent and young adult (AYA) women with sickle cell disease (SCD) have increased pregnancy-related health risks and are prescribed potentially teratogenic medications, yet limited data are available regarding pediatric SCD provider contrace ...
Full textLink to itemCite
Journal ArticleOmega (Westport) · July 20, 2022
The life-limiting and unpredictable nature of sickle cell disease (SCD) is well-established, yet there is limited literature on end-of-life planning. The purpose of this study was to describe perspectives about preparing for death for older adults with SCD ...
Full textLink to itemCite
Journal ArticleJ Thromb Haemost · July 2022
BACKGROUND: Type 3 von Willebrand Disease (VWD) is a rare and severe form of VWD characterized by the absence of von Willebrand factor (VWF). OBJECTIVES: As part of the Zimmerman Program, we sought to explore the molecular pathogenesis, correlate bleeding ...
Full textLink to itemCite
Journal ArticlePilot Feasibility Stud · March 4, 2022
BACKGROUND: The life expectancy for individuals with sickle cell disease (SCD) has greatly increased over the last 50 years. Adults with SCD experience multiple complications such as cardiopulmonary disease, strokes, and avascular necrosis that lead to lim ...
Full textOpen AccessLink to itemCite
ConferenceBlood · November 5, 2021
AbstractBackgroundOver the last five decades, advancements in management of sickle cell disease (SCD) have led to more individuals living beyond the ...
Full textCite
ConferenceBlood · November 5, 2021
AbstractIntroduction: Sickle cell disease (SCD) is the most common hemoglobinopathy in the world and it disproportionately affects population in tropical, resource-constrained regions where there is a high p ...
Full textCite
ConferenceBlood · November 5, 2021
AbstractIntroduction: Pregnancies of women with sickle cell disease (SCD) have increased risk of morbidity and mortality, with potential additional complications due to uncertain teratogenicity of hydroxyure ...
Full textCite
Journal ArticleProteomics Clin Appl · September 2021
PURPOSE: Sickle cell disease (SCD) is an inherited hemoglobinopathy that causes stroke and silent cerebral infarct (SCI). Our aim was to identify markers of brain injury in SCD. EXPERIMENTAL DESIGN: Plasma proteomes were analyzed using a sequential separat ...
Full textLink to itemCite
Journal ArticleJ Pediatr Hematol Oncol · April 1, 2021
INTRODUCTION: Sickle cell disease (SCD) is the most common abnormal genetic blood disease that affects ∼100,000 Americans. Approximately 20% to 37% of children with sickle cell anemia have silent cerebral infarcts by the age of 14 years old. Neurocognitive ...
Full textLink to itemCite
Journal ArticleContemp Clin Trials · February 2021
OBJECTIVES: Painful vaso-occlusive episodes (VOE) are the most common reason for emergency department (ED) visits experienced by patients with sickle cell disease (SCD). The National Heart, Lung and Blood Institute (NHLBI) evidence-based recommendations fo ...
Full textLink to itemCite
ConferenceBlood · November 5, 2020
BackgroundLife expectancy for individuals with sickle cell disease (SCD) has improved significantly in the last 50 years, creating a new population of older adults with SCD; however, life expectancy of adults with S ...
Full textCite
ConferenceBlood · November 5, 2020
BackgroundNearly 95% of individuals with sickle cell disease (SCD) live to become adults (age ≥ 18 years). As individuals with SCD age, they acquire both SCD and age-related complications leading to functional decli ...
Full textCite
Journal ArticleBlood Adv · August 25, 2020
Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. It is a medically and socially complex, multisystem illness that affects individuals throughout the lifespan. Given improvements in care, most children with SCD sur ...
Full textLink to itemCite
Journal ArticleBlood Adv · June 23, 2020
BACKGROUND: The management of acute and chronic pain for individuals living with sickle cell disease (SCD) is a clinical challenge. This reflects the paucity of clinical SCD pain research and limited understanding of the complex biological differences betw ...
Full textOpen AccessLink to itemCite
Journal ArticleJAMA Netw Open · March 2, 2020
IMPORTANCE: Sickle cell disease (SCD) and cystic fibrosis (CF) are severe autosomal recessive disorders associated with intermittent disease exacerbations that require hospitalizations, progressive chronic organ injury, and substantial premature mortality. ...
Full textOpen AccessLink to itemCite
Journal ArticleMagn Reson Med · March 2020
PURPOSE: To evaluate different T2 -oxygenation calibrations for estimating venous oxygenation in people with sickle cell anemia (SCA). METHODS: Blood T2 values were measured at 3 T in the internal jugular veins of 12 healthy volunteers and 11 SCA participa ...
Full textLink to itemCite
Journal ArticlePilot Feasibility Stud · 2020
BACKGROUND: The life expectancy for people with sickle cell disease (SCD) has improved tremendously over the last 50 years. This population experiences hemolysis and vaso-occlusion in multiple organs that lead to complications such as cardiopulmonary disea ...
Full textLink to itemCite
Journal ArticleBlood Adv · December 10, 2019
To address the global burden of sickle cell disease (SCD) and the need for novel therapies, the American Society of Hematology partnered with the US Food and Drug Administration to engage the work of 7 panels of clinicians, investigators, and patients to d ...
Full textOpen AccessLink to itemCite
Journal ArticlePediatr Blood Cancer · December 2019
The transition period from pediatric care to adult care for patients with sickle cell disease (SCD) is associated with increased mortality and morbidity. Identification of risk factors for unsuccessful transition may aid in developing strategies to improve ...
Full textLink to itemCite
Journal ArticleBlood · November 13, 2019
BackgroundDuring the last five decades the life expectancy for people living with sickle cell disease (SCD) has improved markedly, with median survival of 61 years in recent cohorts enrolle ...
Full textOpen AccessCite
ConferenceBlood · November 13, 2019
Sickle cell disease (SCD) is an inherited hemoglobinopathy that frequently causes neurological complications, such as stroke, silent cerebral infarct (SCI) and other forms of brain injury, including loss of cognition. SCI is defined as any ischemic ...
Full textCite
Journal ArticleClin Trials · February 2019
BACKGROUND: Studies of interventions to prevent the many neurological complications of sickle cell disease must take into account multiple outcomes of variable severity, with limited sample size. The goals of the studies presented were to use investigator ...
Full textLink to itemCite
ConferenceBlood · November 29, 2018
AbstractBACKGROUND: Sickle cell disease (SCD) and cystic fibrosis (CF) are rare inherited disorders of similar severity. Disparities in funding between these two diseases have been long recognized and likely ...
Full textCite
ConferenceBlood · November 29, 2018
AbstractRationale: Lower airway disease is common in pediatric sickle cell disease (SCD) and is often diagnosed as asthma. This condition may be a risk factor for acute chest syndrome (ACS) and pain episodes ...
Full textCite
Journal ArticlePLoS Negl Trop Dis · February 2018
BACKGROUND: Dengue is a leading cause of fever and mimics other acute febrile illnesses (AFI). In 2009, the World Health Organization (WHO) revised criteria for clinical diagnosis of dengue. METHODOLOGY/PRINCIPAL FINDINGS: The new WHO 2009 classification o ...
Full textLink to itemCite
Journal ArticleNeurology · January 16, 2018
OBJECTIVE: To evaluate whether application of the adult definition of silent cerebral infarct (SCI) (T2-weighted hyperintensity ≥5 mm with corresponding T1-weighted hypointensity on MRI) is associated with full-scale IQ (FSIQ) loss in children with sickle ...
Full textLink to itemCite
Journal ArticleHum Brain Mapp · January 2018
Baseline hematocrit fraction (Hct) is a determinant for baseline cerebral blood flow (CBF) and between-subject variation of Hct thus causes variation in task-based BOLD fMRI signal changes. We first verified in healthy volunteers (n = 12) that Hct values c ...
Full textLink to itemCite
Journal ArticlePediatr Allergy Immunol Pulmonol · December 1, 2017
A clinician diagnosis of asthma is associated with increased morbidity and mortality in people with sickle cell disease (SCD). We hypothesized that a screening program would help identify children with asthma needing referral to pulmonary clinic. We conduc ...
Full textLink to itemCite
Journal ArticleTransfusion · September 2017
BACKGROUND: Factor (F)XIII deficiency is a rare inherited bleeding disorder, but can also be acquired due to the development of inhibitors. CASE REPORT: A 17-year-old female with systemic lupus erythematosus and end-stage kidney disease secondary to Class ...
Full textOpen AccessLink to itemCite
Journal ArticleMagnetic resonance in medicine · June 2017
PurposeTo develop a fast protocol for measuring T1 values in the internal carotid artery (ICA), to validate this technique with in vitro measurements, and to evaluate its reproducibility.MethodsA modified Look-Locker sequence w ...
Full textCite
Journal ArticleBr J Haematol · January 2017
'Paradoxical' embolization via intracardiac or intrapulmonary right-to-left shunts (RLS) is an established cause of stroke. Hypercoagulable states and increased right heart pressure, which both occur in sickle cell anaemia (SCA), predispose to paradoxical ...
Full textLink to itemCite
ConferenceBlood · December 2, 2016
AbstractBACKGROUND AND OBJECTIVE: In the Silent Cerebral Infarct Trial (SIT), regular blood transfusion therapy significantly reduced the incidence of recurrent cerebral infarctions ...
Full textCite
ConferenceBlood · December 2, 2016
AbstractIntroductionStudies of patients with ischemic stroke and silent cerebral infarcts from sickle cell anemia (SCA) have revealed abnormalities of both large and small ve ...
Full textCite
Journal ArticleInt J Environ Res Public Health · November 12, 2016
Sickle cell disease (SCD) is an autosomal recessive hemoglobinopathy that causes significant morbidity and mortality related to chronic hemolytic anemia, vaso-occlusion, and resultant end-organ damage. Tobacco smoke exposure (TSE) through secondhand smoke ...
Full textOpen AccessLink to itemCite
Journal ArticlePLoS Negl Trop Dis · October 2016
BACKGROUND: Dengue is a frequent cause of acute febrile illness with an expanding global distribution. Since the 1960s, dengue in Sri Lanka has been documented primarily along the heavily urbanized western coast with periodic shifting of serotypes. Outbrea ...
Full textOpen AccessLink to itemCite
Journal ArticleSouth Med J · September 2016
OBJECTIVES: Sickle cell disease (SCD) is associated with high healthcare utilization rates and poor outcomes in a subset of patients, although the underlying factors that predict this phenotype are poorly understood. Prior studies suggest that comorbid ava ...
Full textLink to itemCite
Journal ArticleSouth Med J · September 2016
Sickle cell disease (SCD) is a heterogeneous inherited disorder of hemoglobin that causes chronic hemolytic anemia, vaso-occlusion, and endothelial dysfunction. These physiologic derangements often lead to multiorgan damage in infancy and throughout childh ...
Full textLink to itemCite
Journal ArticleSouth Med J · September 2016
OBJECTIVES: Transcranial Doppler ultrasound (TCD) effectively identifies children with sickle cell anemia (SCA) who are at increased risk of stroke. We evaluated a low-cost quality improvement (QI) intervention to increase the proportion of children screen ...
Full textLink to itemCite
Journal ArticleSouth Med J · September 2016
OBJECTIVES: Neurocognitive dysfunction is an important complication of sickle cell disease (SCD), but little is published on the utility of screening tests for cognitive impairment in people with the disease. The purpose of this study was to evaluate the M ...
Full textLink to itemCite
Journal ArticleSouth Med J · September 2016
OBJECTIVES: Poor oral health can have a negative impact on overall health. This is especially concerning for individuals with sickle cell disease (SCD), an inherited blood disorder that affects hemoglobin and can lead to an increased risk of infection and ...
Full textLink to itemCite
Journal ArticleAm J Prev Med · July 2016
Community health workers are increasingly recognized as useful for improving health care and health outcomes for a variety of chronic conditions. Community health workers can provide social support, navigation of health systems and resources, and lay couns ...
Full textLink to itemCite
Journal ArticleInt J Behav Med · June 2016
PURPOSE: Patients with low educational attainment may be at increased risk for unplanned health care utilization. This study aimed to determine what factors are related to emergency department (ED) visits in hopes of guiding treatments and early interventi ...
Full textLink to itemCite
Journal ArticleJ Pediatr Hematol Oncol · May 2016
Preventive services can reduce the morbidity of sickle cell disease (SCD) in children but are delivered unreliably. We conducted a retrospective cohort study of children aged 2 to 5 years with SCD, evaluating each child for 14 months and expecting that he/ ...
Full textLink to itemCite
Journal ArticleAm J Hematol · March 2016
Tobacco smoke exposure has been associated with more frequent hospitalizations in children with sickle cell disease (SCD), but previous studies have not quantified the exposure by objective methods. We enrolled 50 children and young adults with SCD in a re ...
Full textLink to itemCite
Journal ArticlePediatr Emerg Care · January 2016
OBJECTIVE: The aim of this study was to identify the factors associated with delays in treatment of sickle pain crisis in the pediatric emergency department with the goal of discerning whether earlier pain management is correlated with better clinical outc ...
Full textLink to itemCite
Chapter · 2016
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the sixth amino acid of the β-globin gene (HBB). It is the most common serious genetic diseases in childhood, affecting approximately 1 in 2500 births and 100 000 individual ...
Full textLink to itemCite
Journal ArticleSouth Med J · September 2015
OBJECTIVE: The purpose of this study was to determine the comfort levels of primary care providers in caring for individuals with sickle cell disease (SCD) and determine factors that improved or lessened provider comfort. METHODS: We surveyed providers at ...
Full textLink to itemCite
Journal ArticleAm J Med · May 2015
BACKGROUND: The American Pain Society recommends that individuals experiencing sickle cell crisis receive parenteral pain medication within 30 minutes of assessment. We examined factors affecting achievement of this standard at the Johns Hopkins Sickle Cel ...
Full textLink to itemCite
Journal ArticleBlood · April 2, 2015
Von Willebrand factor (VWF) contains binding sites for platelets and for vascular collagens to facilitate clot formation at sites of injury. Although previous work has shown that VWF can bind type IV collagen (collagen 4), little characterization of this i ...
Full textLink to itemCite
Journal ArticleAm J Hematol · February 2015
The completion of the Multicenter Silent Infarct Transfusion Trial demonstrated that children with pre-existing silent cerebral infarct and sickle cell anemia (SCA) who received regular blood transfusion therapy had a 58% relative risk reduction of infarct ...
Full textLink to itemCite
Journal ArticleJ Pediatr · January 2015
Transcranial Doppler screening reduces the risk of stroke in children with sickle cell disease. We tested the effect of informational letters sent to parents and doctors of Medicaid-insured children on improving screening efficiency. The letters did not im ...
Full textLink to itemCite
ConferenceBlood · December 6, 2014
AbstractIntroduction: Studies have described neuroimaging abnormalities and neurocognitive dysfunction in adults living with sickle cell anemia and no previous history of neurological impairment. At the John ...
Full textCite
Journal ArticleJ Gen Intern Med · December 2014
BACKGROUND: Adults with sickle cell disease (SCD) report experiencing discriminatory behavior from some healthcare providers. The impact of discrimination on health outcomes in SCD, including adherence to physician recommendations, is not known. OBJECTIVE: ...
Full textLink to itemCite
Journal ArticleJ Child Neurol · December 2014
Detecting silent cerebral infarcts on magnetic resonance images (MRIs) in children with sickle cell anemia is challenging, yet reproducibility of readings has not been examined in this population. We evaluated consensus rating, inter-, and intra-grader agr ...
Full textLink to itemCite
Journal ArticleCleft Palate Craniofac J · November 2014
Cleft lip and palate can be associated with coagulopathy. Here, we report the first known case of congenital platelet disorder and von Willebrand disease presenting as prolonged bleeding after cleft lip and palate repair. After identifying the underlying p ...
Full textLink to itemCite
Journal ArticleJ Pain Symptom Manage · November 2014
CONTEXT: Perceived discriminatory experiences in society have been associated with a higher burden of pain among some minority patient populations. OBJECTIVES: To describe the extent to which patients with sickle cell disease (SCD) perceive discrimination ...
Full textLink to itemCite
Journal ArticleAm J Hematol · October 2014
Children with sickle cell anemia have a higher-than-expected prevalence of poor educational attainment. We test two key hypotheses about educational attainment among students with sickle cell anemia, as measured by grade retention and use of special educat ...
Full textLink to itemCite
Journal ArticleN Engl J Med · August 21, 2014
BACKGROUND: Silent cerebral infarcts are the most common neurologic injury in children with sickle cell anemia and are associated with the recurrence of an infarct (stroke or silent cerebral infarct). We tested the hypothesis that the incidence of the recu ...
Full textLink to itemCite
Journal ArticlePatient Educ Couns · August 2014
OBJECTIVE: To assess disparities in the quality of healthcare provider communication experienced by African-American adults with and without sickle cell disease (SCD) in the U.S. METHODS: Poor provider communication was assessed by the Provider Communicati ...
Full textLink to itemCite
Journal ArticleAm J Med · July 2014
BACKGROUND: Successful preventive therapy for ischemic priapism, a disorder of penile erection with major physical and psychologic consequences, is limited. We conducted a randomized, double-blind, placebo-controlled clinical trial to assess the efficacy a ...
Full textLink to itemCite
Journal ArticleClin Trials · June 2014
Background A substantial number of planned clinical trials for sickle cell disease (SCD) have terminated early due to insufficient patient enrollment. Purpose To describe attitudes toward clinical trials among a sample of adults with SCD and identify patie ...
Full textLink to itemCite
Journal ArticlePediatr Blood Cancer · May 2014
BACKGROUND: Respiratory syncytial virus (RSV) is a cause of acute chest syndrome (ACS) in sickle cell disease (SCD), but its clinical course and acute complications have not been well characterized. We compared RSV to seasonal influenza infections in child ...
Full textLink to itemCite
Journal ArticleBlood Cells Mol Dis · April 2014
Sickle cell disease (SCD) is associated with increase in oxidative stress and irreversible membrane changes that originates from the instability and polymerization of deoxygenated hemoglobin S (HbS). The relationship between erythrocyte membrane changes as ...
Full textLink to itemCite
Journal ArticleJ Pediatr Hematol Oncol · March 2014
AIM: To evaluate the use of a computerized physician order entry (CPOE) protocol on manual red blood cell (RBC) exchange transfusion in critically ill children with sickle cell disease. METHODS: We conducted a retrospective study of children with sickle ce ...
Full textLink to itemCite
Journal ArticleJ Pediatr · February 2014
OBJECTIVE: To determine incidence and clinical characteristics of hospital-associated venous thromboembolism (VTE) in pediatric patients. STUDY DESIGN: A retrospective analysis of patients with hospital-associated VTE at the Johns Hopkins Hospital from 199 ...
Full textLink to itemCite
Journal ArticleAm J Hematol · February 2014
Children with sickle cell anemia have a high prevalence of silent cerebral infarcts (SCIs) that are associated with decreased full-scale intelligence quotient (FSIQ). While the educational attainment of parents is a known strong predictor of the cognitive ...
Full textLink to itemCite
ConferenceBlood · November 15, 2013
AbstractIntroductionPerceived discrimination due to race or ethnicity has been associated with a greater burden of pain among minority ...
Full textCite
ConferenceBlood · November 15, 2013
AbstractIntroductionVenous thromboembolism (VTE) is increasing in children, especially in the tertiary care setting. Hospital-associat ...
Full textCite
Journal ArticlePediatr Blood Cancer · April 2013
BACKGROUND: Individuals with sickle cell disease (SCD) have an increased risk of cholelithiasis from bilirubin stones. Symptomatic biliary tract disease (BTD) includes acute and chronic cholecystitis, obstruction of the common bile duct (CBD), cholangitis, ...
Full textLink to itemCite
Journal ArticleJ Hematol Oncol · February 17, 2013
BACKGROUND: Platelet activation has been implicated in the pathogenesis of sickle cell disease (SCD) suggesting antiplatelet agents may be therapeutic. To evaluate the safety of prasugrel, a thienopyridine antiplatelet agent, in adult patients with SCD, we ...
Full textLink to itemCite
Journal ArticlePLoS One · 2013
BACKGROUND: Chikungunya virus (CHIKV) re-emerged in Sri Lanka in late 2006 after a 40-year hiatus. We sought to identify and characterize acute chikungunya infection (CHIK) in patients presenting with acute undifferentiated febrile illness in unstudied rur ...
Full textOpen AccessLink to itemCite
Journal ArticleASAIO J · 2013
The best method of monitoring anticoagulation during extracorporeal membrane oxygenation (ECMO) is unknown. We conducted a prospective observational study in a tertiary pediatric intensive care unit. Antifactor Xa, antithrombin (AT), and factor VIII activi ...
Full textLink to itemCite
Journal ArticleJAMA Neurol · January 2013
BACKGROUND: Irregular, sporadic episodes of ischemic brain injury are known to occur in sickle cell anemia (SCA), resulting in overt stroke and silent cerebral infarction. Ongoing ischemia in other organs is common in SCA but has never been documented in t ...
Full textLink to itemCite
Journal ArticleCase Rep Hematol · 2013
Although individuals with sickle cell disease (SCD) are at increased risk for stroke, the underlying pathophysiology is incompletely understood. Intracardiac shunting via a patent foramen ovale (PFO) is associated with cryptogenic stroke in individuals wit ...
Full textLink to itemCite
ConferenceBlood · November 16, 2012
AbstractAbstract 2058Background:Healthcare professionals caring for patients with sickle cell disease ...
Full textCite
Journal ArticlePediatr Blood Cancer · November 2012
BACKGROUND: Sickle cell disease (SCD) requires coordinated ambulatory care from generalists and hematologists. We examined when children with SCD establish ambulatory care connections, whether these connections are maintained, and how these connections are ...
Full textLink to itemCite
Journal ArticlePediatr Blood Cancer · August 2012
Hydroxyurea is the only approved medication in the United States for the treatment of sickle cell anemia (HbSS) and is widely used in children despite an indication limited to adults. We review the evidence of efficacy and safety in children with reference ...
Full textLink to itemCite
Journal ArticleCancer · May 15, 2012
BACKGROUND: Data on sentinel lymph node (SLN) biopsy in children with melanoma are limited. In this study, the authors compared the factors associated with SLN biopsy use and metastases in pediatric and young adult patients with melanoma. METHODS: The 2008 ...
Full textLink to itemCite
Journal ArticleEmerg Infect Dis · May 2012
We studied rickettsioses in southern Sri Lanka. Of 883 febrile patients with paired serum samples, 156 (17.7%) had acute rickettsioses; rickettsioses were unsuspected at presentation. Additionally, 342 (38.7%) had exposure to spotted fever and/or typhus gr ...
Full textLink to itemCite
Journal ArticleBlood · April 19, 2012
The most common form of neurologic injury in sickle cell anemia (SCA) is silent cerebral infarction (SCI). In the Silent Cerebral Infarct Multi-Center Clinical Trial, we sought to identify risk factors associated with SCI. In this cross-sectional study, we ...
Full textLink to itemCite
Journal ArticleEmerg Infect Dis · February 2012
Dengue virus (DENV), a globally emerging cause of undifferentiated fever, has been documented in the heavily urbanized western coast of Sri Lanka since the 1960s. New areas of Sri Lanka are now being affected, and the reported number and severity of cases ...
Full textLink to itemCite
Journal ArticleEmerging Infectious Diseases · 2012
We studied rickettsioses in southern Sri Lanka. Of 883 febrile patients with paired serum samples, 156 (17.7%) had acute rickettsioses; rickettsioses were unsuspected at presentation. Additionally, 342 (38.7%) had exposure to spotted fever and/or typhus gr ...
Full textCite
Journal ArticleExpert Rev Hematol · December 2011
Stroke is a frequent and severe complication in adults with sickle cell disease. Ischemic stroke often causes physical and cognitive disability, while hemorrhagic stroke has a high mortality rate. As more children survive, the number of strokes in adults i ...
Full textLink to itemCite
Journal ArticlePediatr Crit Care Med · September 2011
OBJECTIVE: To determine whether, in children, plasma glial fibrillary acidic protein is associated with brain injury during extracorporeal membrane oxygenation and with mortality. DESIGN: Prospective, observational study. SETTING: Pediatric intensive care ...
Full textLink to itemCite
Journal ArticleEmerg Infect Dis · September 2011
To determine the proportion of fevers caused by leptospirosis, we obtained serum specimens and epidemiologic and clinical data from patients in Galle, Sri Lanka, March-October 2007. Immunoglobulin M ELISA was performed on paired serum specimens to diagnose ...
Full textLink to itemCite
Journal ArticleJ Pediatr Hematol Oncol · July 2011
Consumptive coagulopathy is a known complication of large vascular tumors. We describe 2 episodes of consumptive coagulopathy in young children, which were secondary to isolated splenic vascular tumors. One child was successfully treated by subtotal emboli ...
Full textLink to itemCite
Journal ArticleMagn Reson Med · May 2011
Current T(1) values for blood at 3T largely came from in vitro studies on animal blood or freshly drawn human blood. Measurement of blood T(1) in vivo could provide more specific information, e.g., for individuals with abnormal blood composition. Here, blo ...
Full textLink to itemCite
Journal ArticleAcad Pediatr · 2011
OBJECTIVE: Children with sickle cell disease (SCD) often receive care in the emergency department (ED), but the urgency of these frequent visits is not well understood. This study examined ED use by children with SCD by comparing the urgency of ED visits a ...
Full textLink to itemCite
Journal ArticleBlood · November 4, 2010
Influenza causes excess morbidity in sickle cell disease (SCD). H1N1 pandemic influenza has been severe in children. To compare H1N1 with seasonal influenza in SCD (patients younger than 22), we reviewed medical records (1993-2009). We identified 123 cases ...
Full textLink to itemCite
Journal ArticlePediatrics · July 2010
OBJECTIVE: We describe the prevalence and range of incidental intracranial abnormalities identified through MRI of the brain in a large group of children screened for a clinical trial. METHODS: We included 953 children between 5 and 14 years of age who wer ...
Full textLink to itemCite
Journal ArticlePediatr Hematol Oncol · March 2010
BACKGROUND: Silent cerebral infarct (SCI) is the most common cause of serious neurological disease in sickle cell anemia (SCA), affecting approximately 22% of children. The goal of this trial is to determine whether blood transfusion therapy will reduce fu ...
Full textLink to itemCite
Journal ArticlePediatrics · February 2010
OBJECTIVE: Children with sickle cell disease (SCD) are considered to be at high risk for complications from influenza infection despite minimal published data that characterize the burden of influenza in this population. Our objectives were to (1) estimate ...
Full textLink to itemCite
Journal ArticleJ Natl Med Assoc · October 2009
Clinical experts have expressed concern about underutilization of sickle cell disease (SCD) therapies, including hydroxyurea, prophylactic antibiotics, iron chelation, bone marrow transplantation, pain management during vaso-occlusive crisis, and receipt o ...
Full textLink to itemCite
Journal ArticleAm J Hematol · September 2009
This report compares the relative rates and risk factors associated with stroke in adults versus children with sickle cell disease (SCD) in the United States over the last decade. We identified incident strokes in patients with SCD using ICD-9 codes for ac ...
Full textLink to itemCite
Journal ArticleJ Pediatr Adolesc Gynecol · June 2009
BACKGROUND: Although iliac vein thrombus is uncommon in adolescents, it can present with pelvic inflammatory disease (PID) symptoms. CASE: A 19-year-old sexually active female with Klippel-Trénaunay syndrome (KTS) presented with fever, abdominal and lower ...
Full textLink to itemCite
Journal ArticlePediatrics · December 2008
CONTEXT: Hydroxyurea is the only approved medication for the treatment of sickle cell disease in adults; there are no approved drugs for children. OBJECTIVE: Our goal was to synthesize the published literature on the efficacy, effectiveness, and toxicity o ...
Full textLink to itemCite
Journal ArticleAnn Intern Med · June 17, 2008
BACKGROUND: Hydroxyurea is the only approved drug for treatment of sickle cell disease. OBJECTIVE: To synthesize the published literature on the efficacy, effectiveness, and toxicity of hydroxyurea when used in adults with sickle cell disease. DATA SOURCES ...
Full textLink to itemCite
Journal ArticlePediatr Blood Cancer · May 2008
We present the cases of two patients with severe congenital neutropenia (SCN) who both developed generalized adenopathy. Although both had recent histories that placed infection high on the differential of causes for the adenopathy, biopsies demonstrated a ...
Full textLink to itemCite
Journal ArticlePediatr Blood Cancer · May 2008
BACKGROUND: Acute chest syndrome (ACS) is a frequent cause of hospitalization and mortality in children with sickle cell disease. Transfusion is often required to prevent respiratory failure and treatment with dexamethasone may reduce the length of admissi ...
Full textLink to itemCite
Journal ArticleNat Genet · May 2008
Iron deficiency is usually attributed to chronic blood loss or inadequate dietary intake. Here, we show that iron deficiency anemia refractory to oral iron therapy can be caused by germline mutations in TMPRSS6, which encodes a type II transmembrane serine ...
Full textLink to itemCite
Journal ArticleEvid Rep Technol Assess (Full Rep) · March 2008
OBJECTIVES: To synthesize the published literature on the efficacy, effectiveness, and toxicity of hydroxyurea (HU) when used for treatment of sickle cell disease (SCD); and to review the evidence regarding barriers to its use. DATA SOURCES: Articles cited ...
Link to itemCite
ConferenceBlood · November 16, 2007
AbstractMost studies of survival in sickle cell disease (SCD) include only patients followed at referral centers. We used the public set of the California Patient Discharge Databases (1998–2005) to compare i ...
Full textCite
Journal ArticleBlood · November 16, 2006
AbstractHeadache and other symptoms and signs of possible CNS disease are common in children with sickle cell disease (SCD). Computerized tomography (CT) is a rapid and widely available method to image the s ...
Full textCite
Journal ArticlePediatrics · November 2006
OBJECTIVES: Primary hemorrhagic stroke is an uncommon complication of sickle cell disease, with reported mortality rates of 24% to 65%. Most reported cases are in adults; little is known about its occurrence in children. Proposed risk factors include previ ...
Full textLink to itemCite
Journal ArticleBlood · July 1, 2006
Overt stroke, clinically "silent" cerebral infarct, and neurocognitive impairment are frequent complications of sickle cell anemia (SCA). Current imaging techniques have limited sensitivity and specificity to identify children at risk for neurocognitive im ...
Full textLink to itemCite
ConferenceBlood · November 16, 2005
AbstractAcute chest syndrome (ACS) is a cause of frequent hospitalization and death in patients with sickle cell disease (SCD). Therapies commonly used include antibiotics, inhaled B-agonists, oxygen, high-d ...
Full textCite
Journal ArticleJ Clin Oncol · July 20, 2005
PURPOSE: To evaluate risk factors for the development of and factors influencing survival in pediatric melanoma. PATIENTS AND METHODS: We evaluated 1,255 children (age < 20 years) and 2,673 young adults (age 20 to 24 years) with melanoma in the 2001 Nation ...
Full textLink to itemCite
Journal ArticlePediatr Blood Cancer · April 2005
Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combi ...
Full textLink to itemCite
ConferenceBlood · November 16, 2004
Background: Intracranial hemorrhage (ICH) is an uncommon, but devastating, complication of sickle cell disease (SCD) with mortality from 30 to 65%. Most reported cases are in adults; little is known about children. Proposed risk factors include pre ...
Full textCite
Journal ArticleAm J Trop Med Hyg · April 2004
Hematocrit levels were determined in 36 mothers living at high altitudes (3,750 meters) and their infant cord bloods to determine the effect of maternal anemia on the infant. The arterial oxygen saturation (SaO(2)) and respiratory rate of the infants were ...
Link to itemCite
ConferenceBotanical Journal of the Linnean Society · January 1, 1996
Mahogany (Swietenia macrophylla King) regeneration in areas of erosion on high terraces and in forest killed by flooding and deposition of alluvial sediments in the Chimanes Forest, Bolivia. These hydrological disturbances are patchy, and only one of five ...
Full textCite